Hikma Pharmaceuticals PLC 2013 SR
The report highlights Hikma's 2013 sustainability efforts, focusing on patient access to affordable medicines, economic contribution, and environmental impact. Key achievements include launching 69 new products, investing $76 million in R&D, and expanding into sub-Saharan Africa via a joint venture in Ethiopia. The company also implemented a Group-wide Good Pharmacovigilance Practice policy and reported its greenhouse gas emissions for the first time under new guidelines. Additionally, Hikma focused on community support through medicine donations and employee volunteering initiatives.
Company: Hikma Pharmaceuticals PLC
Sector: Manufacturing
Country: United Kingdom
Year: 2013
Type: SR
Pages: 8
Back to company
Hikma Pharmaceuticals PLC
Sustainability Report
The report highlights Hikma's 2013 sustainability efforts, focusing on patient access to affordable medicines, economic contribution, and environmental impact. Key achievements include launching 69 new products, investing $76 million in R&D, and expanding into sub-Saharan Africa via a joint venture in Ethiopia. The company also implemented a Group-wide Good Pharmacovigilance Practice policy and reported its greenhouse gas emissions for the first time under new guidelines. Additionally, Hikma focused on community support through medicine donations and employee volunteering initiatives.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2013
Reporting Period
Jan 1, 2013 - Dec 31, 2013
Fiscal Year
2013
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Other Standards
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Employees